Table 1.
Breast invasive ductal carcinoma patient’s clinicopathological features
| |||
---|---|---|---|
Variable | n (%) | ||
| |||
Age (Y) | |||
<47 | 44 (48.88) | ||
≥47 | 46 (51.11) | ||
T stage | |||
T1 ≤2 | 38 (42.22) | ||
T2 | }>2 | 15 (16.67) | |
T3 | 19 (21.11) | ||
T4 | 18 (20) | ||
Lymph node involvement | |||
Positive | 54 (60) | ||
Negative | 36 (40) | ||
Metastasis status | |||
Metastatic | 30 (33.33) | ||
Non-metastatic | 60 (66.67) | ||
Clinical TNM staging | |||
I | 30 (33.33) | ||
II and III | 30 (33.33) | ||
IV | 30 (33.33) | ||
|
TNM; Tumor, nodes, and metastases.